NCT02186470View on ClinicalTrials.gov

Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

April 29, 2016

Primary Completion Date

September 4, 2025

Study Completion Date

September 4, 2025

Conditions
Estrogen Receptor-positive Breast CancerInvasive Ductal Breast CarcinomaInvasive Ductal Breast Carcinoma With Predominant Intraductal ComponentMedullary Ductal Breast Carcinoma With Lymphocytic InfiltrateMucinous Ductal Breast CarcinomaPapillary Ductal Breast CarcinomaProgesterone Receptor-positive Breast CancerStage IA Breast CancerStage IB Breast CancerTubular Ductal Breast Carcinoma
Interventions
RADIATION

accelerated partial breast irradiation

Undergo image-guided intensity-modulated APBI

RADIATION

intensity-modulated radiation therapy

Undergo image-guided intensity-modulated APBI

RADIATION

image-guided radiation therapy

Undergo image-guided intensity-modulated APBI

PROCEDURE

therapeutic conventional surgery

Lumpectomy

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

All Listed Sponsors
lead

Ohio State University Comprehensive Cancer Center

OTHER

NCT02186470 - Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer | Biotech Hunter | Biotech Hunter